It is a link for moving within the page.

  1. HOME
  2. About Otsuka
  3. News Releases
  4. 2018
  5. Otsuka Pharmaceutical Establishes Subsidiary in Singapore

May 23, 2018

Otsuka Pharmaceutical Co.,Ltd.

Pharmaceuticals

Otsuka Pharmaceutical Establishes Subsidiary in Singapore

Otsuka Pharmaceutical Co., Ltd. (Otsuka) announces the establishment of a new foreign subsidiary, Otsuka Pharmaceutical (Singapore), which held an opening ceremony on May 22.

Opening Ceremony

Otsuka prescription medicines such as its antipsychotic medication ABILIFY are sold through agents. As Otsuka advances toward the introduction of innovative new products in Singapore and in the neighboring countries of Malaysia, Cambodia and Myanmar, the decision was made to establish a local subsidiary. This subsidiary will oversee the agency business, and thereby further promote the availability of Otsuka medicines in the region.

In the 10-member ASEAN regional bloc (Singapore, Thailand, Indonesia, Vietnam, Philippines, Malaysia, Myanmar, etc.) access to medical services is steadily improving as income levels rise and healthcare delivery systems become more advanced. For these reasons and others, such as an increase in lifestyle-related diseases, Otsuka anticipates that robust health sector growth will continue. Singapore, which is a regional economic hub, actively promotes medical tourism and prioritizes the biomedical sector as national strategies, therefore a direct presence there will facilitate Otsuka's involvement in healthcare in Singapore and beyond.

Hiroaki Tanaka has been appointed as president of the subsidiary.


Information in this news release was current as of the original release date.

Latest Pharmaceutical Business related News Releases

Most Recent Releases